Version Française

Develop quality in the health,
social and medico-social field

Search

impression
Opinions on drugs

RENAGEL

Active substance (DCI)
  • Sevelamer

Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and on the list of medicines approved for use by hospitals and various public services in the new indication: “RENAGEL is indicated for the control of hyperphosphataemia in adult patients receiving peritoneal dialysis”.

Date 11 June 2008

Actual benefit

Important Le service médical rendu par RENAGEL est important dans la nouvelle indication : contrôle de l’hyperphosphorémie chez l’adulte en dialyse péritonéale.


Improvement in actual benefit

V (absence) Dans l'extension d'indication chez les patients en dialyse péritonéale, RENAGEL n'apporte pas d'amélioration du service médical rendu (ASMR V) dans la stratégie thérapeutique.


Documents

ATC Code
  • V03AE02
Laboratory / Manufacturer
GENZYME SAS

Presentation

RENAGEL 400 mg, film-coated tablet:
Pack of 360. CIP code: 357 264-2
RENAGEL 800 mg, film-coated tablet:
Pack of 180. CIP code: 357 265-9

Posted on Apr 20 2009